Herpes zoster-associated encephalitis in a patient undergoing capd : Case report and literature reviewSIGALOFF, Kim C. E; DE FIJTER, Carola W. H.Peritoneal dialysis international. 2007, Vol 27, Num 4, pp 391-394, issn 0896-8608, 4 p.Article

Cecal diverticulitis in an adolescentSIGALOFF, Kim C. E; VAN DEN BERG, José G; BENNINGA, Marc A et al.Journal of pediatric gastroenterology and nutrition. 2005, Vol 40, Num 5, pp 603-605, issn 0277-2116, 3 p.Article

Global Response to HIV: Treatment as Prevention, or Treatment for Treatment?SIGALOFF, Kim C. E; LANGE, Joep M. A; MONTANER, Julio et al.Clinical infectious diseases. 2014, Vol 59, issn 1058-4838, S7-S11, SUP1Conference Paper

Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South AfricaSIGALOFF, Kim C. E; RAMATSEBE, Tina; VIANA, Raquel et al.AIDS research and human retroviruses. 2012, Vol 28, Num 2, pp 171-175, issn 0889-2229, 5 p.Article

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational studyHAMERS, Raph L; WALLIS, Carole L; NANKYA, Immaculate et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 750-759, issn 1473-3099, 10 p.Article

Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in KampalaNDEMBI, Nicaise; HAMERS, Raph L; SIGALOFF, Kim C. E et al.AIDS (London). 2011, Vol 25, Num 7, pp 905-910, issn 0269-9370, 6 p.Article

Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling studyNICHOLS, Brooke E; SIGALOFF, Kim C. E; KITYO, Cissy et al.AIDS (London). 2014, Vol 28, Num 1, pp 73-84, issn 0269-9370, 12 p.Article

Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan AfricaSIGALOFF, Kim C. E; HAMERS, Raph L; STEVENS, Wendy S et al.The Journal of infectious diseases. 2012, Vol 205, Num 11, pp 1739-1744, issn 0022-1899, 6 p.Article

Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance NetworkHAMERS, Raph L; STRAATSMA, Elske; WELLINGTON, Maureen et al.Clinical infectious diseases. 2012, Vol 54, issn 1058-4838, S261-S265, SUP4Article

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort studyHAMERS, Raph L; SCHUURMAN, Rob; OSIBOGUN, Akin et al.Lancet. Infectious diseases (print). 2012, Vol 12, Num 4, pp 307-317, issn 1473-3099, 11 p.Article

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART StrategiesHAMERS, Raph L; SIGALOFF, Kim C. E; OSIBOGUN, Akin et al.Clinical infectious diseases. 2012, Vol 54, Num 11, pp 1660-1669, issn 1058-4838, 10 p.Article

Short Communication High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, KenyaSIGALOFF, Kim C. E; MANDALIYA, Kishor; HAMERS, Raph L et al.AIDS research and human retroviruses. 2012, Vol 28, Num 9, pp 833-837, issn 0889-2229, 5 p.Article

Early Warning Indicators for Population-Based Monitoring of HIV Drug Resistance in 6 African CountriesSIGALOFF, Kim C. E; HAMERS, Raph L; OSIBOGUN, Akin et al.Clinical infectious diseases. 2012, Vol 54, issn 1058-4838, S294-S299, SUP4Article

Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in AfricaSIGALOFF, Kim C. E; HAMERS, Raph L; STEVENS, Wendy S et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 1, pp 23-31, issn 1525-4135, 9 p.Article